IMAPAC Glossary

An Absorption Window is the gastrointestinal region where a drug is most efficiently absorbed into systemic circulation.

Accelerated Approval is an FDA regulatory pathway that expedites access to therapies for serious diseases using surrogate endpoints while requiring confirmatory post-marketing studies.

Accelerated stability testing evaluates pharmaceutical stability under elevated environmental conditions to predict long-term storage performance and shelf life.

Acid-base equilibrium in formulation describes the balance between ionised and non-ionised species that influences pH, stability and drug solubility.

The Acid Dissociation Constant (pKa) measures a compound's tendency to donate a proton and determines its ionisation state at different pH values.

The actin cytoskeleton is a dynamic network of protein filaments that provides structural support, enables cell movement and regulates intracellular transport and cell division.

An Active Pharmaceutical Ingredient (API) is the biologically active substance in a medicine that produces its intended therapeutic effect.

Adaptive immunity is the antigen-specific immune response mediated by B and T lymphocytes that provides long-term protection and immunological memory.

Adeno-Associated Virus (AAV) is a non-pathogenic viral vector widely used to deliver therapeutic genes in gene therapy due to its safety and long-term expression.

Adenosine receptor modulation alters adenosine receptor signalling to regulate inflammation, cardiovascular function, neurological activity and immune responses.

An adjuvant system combines multiple immunostimulatory components to enhance vaccine-induced immune responses beyond those achieved by a single adjuvant.

Adsorption is the accumulation of molecules onto the surface of a solid or liquid, influencing pharmaceutical stability, purification and drug delivery.

An Adverse Event (AE) is any unfavourable medical occurrence experienced during treatment, regardless of whether it is caused by the therapy.

Aerosol generation is the production of fine airborne particles or droplets for applications such as inhaled drug delivery, laboratory procedures and manufacturing processes.

Affinity chromatography is a purification technique that selectively isolates biomolecules through highly specific binding interactions between a target molecule and an immobilised ligand.

Affinity maturation is the natural or engineered process of improving an antibody's binding affinity for its target antigen.

Affinity Purification is a chromatography technique that selectively isolates target biomolecules using highly specific binding interactions with immobilised ligands.

Agglomeration is the clustering of particles, cells or biomolecules into loosely bound masses that can affect product quality and manufacturing performance.

Aggregate analysis characterises protein aggregates and particulate species that may affect the quality, safety and efficacy of biopharmaceutical products.

Aggregation is the formation of protein or particle clusters that can reduce product stability, efficacy and safety while increasing immunogenicity risk.

Albumin binding is the reversible interaction between therapeutic compounds and serum albumin that influences drug distribution, half-life and pharmacokinetics.

An aliquot is a measured portion of a larger sample that is separated for testing, storage or experimental use.

An allele is one of two or more alternative forms of a gene that contributes to genetic variation and inherited traits.

An allergen is a substance capable of triggering an immune response that results in allergic reactions in susceptible individuals.

Allometric scaling predicts human pharmacokinetic or physiological parameters from animal data using mathematical relationships based on body size and species differences.

An allosteric inhibitor binds to a regulatory site distinct from the active site to reduce or modify the activity of a target protein.

An allosteric modulator is a molecule that alters protein activity by binding to a site other than the primary active or binding site.

An amino acid sequence is the ordered arrangement of amino acids in a protein that determines its structure and biological function.

An amphiphile is a molecule containing both hydrophilic and hydrophobic regions that enable the formation of micelles, membranes and lipid nanoparticles.

Amyloid formation is the aggregation of misfolded proteins into highly ordered fibrillar structures associated with neurodegenerative and systemic diseases.

Analytical method transfer is the documented process of transferring a validated analytical procedure between laboratories while demonstrating equivalent performance.

Analytical Method Validation is the process of demonstrating that an analytical procedure consistently produces accurate, reliable and reproducible results.

Analytical ultracentrifugation is a high-speed centrifugation technique used to characterise the size, shape, molecular weight and interactions of biological macromolecules.

Angiogenesis is the formation of new blood vessels from existing vasculature, supporting normal tissue growth, wound healing and tumour progression.

Animal model selection is the process of choosing the most appropriate experimental species or disease model to support biomedical research and drug development.

Antibody affinity is the strength of interaction between a single antigen-binding site of an antibody and its specific antigenic epitope.

An Antibody Drug Conjugate (ADC) is a targeted therapy that combines a monoclonal antibody with a potent cytotoxic drug to selectively destroy diseased cells.

Antibody engineering is the modification of antibody structure to improve binding affinity, specificity, stability, safety or therapeutic function.

Antibody isotype refers to the immunoglobulin class or subclass that determines an antibody's structural characteristics and biological effector functions.

An antigen is a molecule recognised by the immune system that can trigger the production of antibodies or activate immune cells.

An antigen-antibody complex is the molecular structure formed when an antibody specifically binds to its target antigen, initiating immune recognition or clearance.

An Antigen Presenting Cell (APC) is an immune cell that processes and presents antigens to T cells to initiate adaptive immune responses.

Antigen processing is the intracellular breakdown and presentation of antigens for recognition by T lymphocytes during adaptive immune responses.

Antimicrobial resistance is the ability of microorganisms to survive antimicrobial treatments, reducing the effectiveness of medicines used to control infections.

An antisense oligonucleotide is a short synthetic nucleic acid designed to bind RNA and modify gene expression for therapeutic purposes.

An antiviral mechanism describes the biological process by which a therapeutic agent inhibits viral infection, replication or spread.

Apheresis is a medical procedure that separates and collects specific blood components while returning the remaining constituents to the patient or donor.

Apoptosis is the regulated process of programmed cell death that removes damaged or unnecessary cells while maintaining tissue homeostasis.

Apoptosis induction is the activation of programmed cell death pathways to eliminate damaged, infected or malignant cells in a controlled manner.

An Application Programming Interface (API) in digital health enables software systems to securely exchange healthcare, laboratory or clinical information.

Aptamer discovery is the process of identifying nucleic acid sequences that bind specific molecular targets with high affinity and selectivity.

An aptamer-drug conjugate combines a target-specific aptamer with a therapeutic payload to enable selective drug delivery.

Aptamer technology uses short nucleic acid sequences that bind specific molecular targets with high affinity for diagnostic and therapeutic applications.

Aqueous solubility is the ability of a compound to dissolve in water, influencing formulation, bioavailability and therapeutic performance.

Arrhythmia risk assessment evaluates the potential of therapeutic compounds to disrupt normal cardiac rhythm and cause clinically significant arrhythmias.

Artificial intelligence in drug discovery applies machine learning and computational algorithms to accelerate target identification, compound optimisation and predictive modelling.

Aseptic filling is the sterile transfer of pharmaceutical products into final containers under controlled conditions to prevent microbial contamination.

Aseptic processing is the manufacture and filling of sterile pharmaceutical products under controlled conditions to maintain product sterility throughout production.

Aseptic technique comprises procedures that prevent microbial contamination during laboratory work, pharmaceutical manufacturing and clinical practice.

Assay development is the process of designing, optimising and validating analytical tests to accurately measure biological or chemical properties.

Assay interference occurs when external factors or sample components produce inaccurate analytical results by affecting assay performance or signal detection.

Assay sensitivity is the ability of an analytical method to detect or accurately measure low concentrations of a target analyte.

Atmospheric pressure ionisation is a mass spectrometry ionisation technique that generates gas-phase ions under atmospheric conditions for molecular analysis.

Attribute Based Release is a quality approach that uses validated process and analytical data to support product release with reduced reliance on end-product testing.

Attrition rate is the proportion of drug candidates or clinical study participants that fail, withdraw or discontinue during the development process.

An autoclave is a sterilisation device that uses high-pressure saturated steam to eliminate microorganisms from equipment, materials and laboratory waste.

Autocrine signalling is a form of cellular communication in which cells release signalling molecules that act on receptors located on the same cell.

Autologous refers to cells, tissues or biological materials collected from and administered back to the same individual.

Autologous stem cell transplantation uses a patient's own stem cells to restore bone marrow function following high-dose chemotherapy or other intensive treatments.

Automation is the use of control systems, software and robotics to improve efficiency, consistency and accuracy in biopharmaceutical manufacturing.

Autophagic flux describes the complete process of autophagosome formation, cargo degradation and lysosomal recycling within the autophagy pathway.

An autoreactive lymphocyte is an immune cell that recognises and reacts against the body's own tissues, contributing to autoimmune disease.

An auxotroph is a microorganism or cell that cannot synthesise a required nutrient and must obtain it from its environment.

Avidity is the overall strength of binding between a multivalent antibody and its corresponding antigen, reflecting the combined effect of multiple interactions.

Avoidance of bias in clinical trials uses study design and operational controls to minimise systematic errors that could influence trial outcomes.

Axonal transport is the intracellular movement of proteins, organelles and signalling molecules along neuronal axons to maintain nerve cell function.

Azide chemistry uses azide functional groups in highly selective chemical reactions for applications including bioconjugation, click chemistry and molecular labelling.

Azithromycin-like antimicrobial development focuses on designing macrolide antibiotics with improved antimicrobial activity, safety and resistance profiles.

An azurophil granule is a specialised lysosomal granule within neutrophils containing antimicrobial enzymes and proteins that destroy invading pathogens.

Bacteriophage therapy uses viruses that specifically infect bacteria as targeted treatments for bacterial infections, including antimicrobial-resistant pathogens.

Basophil activation is the stimulation of basophils to release histamine and other inflammatory mediators during allergic and immune responses.

A batch contamination investigation is a structured quality process used to identify the source, impact and corrective actions associated with suspected product contamination.

Batch genealogy is the complete documented history of materials, components and manufacturing activities used to produce a pharmaceutical batch, ensuring full traceability.

A batch record is a controlled document that captures all manufacturing activities, materials and quality checks performed during production.

Batch release is the formal process of verifying that a manufactured batch meets all quality and regulatory requirements before distribution.

Bayesian statistics in clinical trials is a statistical approach that combines prior knowledge with accumulating study data to continuously update treatment effect estimates.

Biased agonism is the ability of different ligands acting on the same receptor to selectively activate specific signalling pathways while avoiding others.

The bicinchoninic acid (BCA) assay is a colorimetric analytical method used to accurately determine protein concentration by measuring copper ion reduction.

Binding affinity is the strength of interaction between two molecules, such as an antibody and its antigen or a drug and its target.

Bioactivity is the measurable biological effect of a therapeutic product that demonstrates its intended mechanism of action.

Bioanalytical Method Validation confirms that analytical methods used to measure biological samples produce accurate, reliable and reproducible results.

Biobanking is the systematic collection, processing and storage of biological samples for research, clinical and therapeutic applications.

Bioburden is the number of viable microorganisms present on a material, product or manufacturing environment before sterilisation.

Biocatalysis uses enzymes or whole cells to accelerate chemical reactions with high specificity under mild manufacturing conditions.

A biocluster is a geographic concentration of biotechnology, pharmaceutical, academic and healthcare organisations that collaborate to accelerate innovation and commercialisation.

Biocompatibility testing evaluates whether a material or medical device performs safely without causing unacceptable biological or toxicological responses.

Bioconjugation is the chemical or biological linking of two molecules to create products with enhanced therapeutic, diagnostic or analytical properties.

Biocontainment comprises the practices, equipment and facility controls used to prevent the release of hazardous biological materials.

Biodefence involves measures and technologies designed to protect people, infrastructure and public health from biological threats.

A biodegradable polymer is a material that naturally breaks down into simpler substances through biological or environmental processes.